<span id="midArticle_start"/>May 27 Ab Science SA :
<span id="midArticle_0"/>* Phase 2 with Masitinib in peripheral T-cell lymphomaaccelerated into phase 3
<span id="midArticle_1"/> <span class="first-article-divide"/> <span class="second-article-divide"/>Source text for Eikon: Further company coverage: (Gdynia Newsroom)
<span id="midArticle_2"/> <span class="third-article-divide"/>
<span id="midArticle_0"/>* Phase 2 with Masitinib in peripheral T-cell lymphomaaccelerated into phase 3
<span id="midArticle_1"/> <span class="first-article-divide"/> <span class="second-article-divide"/>Source text for Eikon: Further company coverage: (Gdynia Newsroom)
<span id="midArticle_2"/> <span class="third-article-divide"/>
via Smart Health Shop Forum http://ift.tt/1cjsWwE
No comments:
Post a Comment